Petco Health And Wellness Company (WOOF) valuation
Petco Health And Wellness P/E ratio history
Petco Health And Wellness trades at 26.1 times its earnings over the last twelve months and 9.9 times the earnings analysts expect over the next twelve. At its last 3 fiscal year ends its P/E ranged from 29.5 (year to Jan 2022) to 89.7 (year to Jan 2026), with a median of 34.5.
| Fiscal year ended | Price | EPS | P/E | Forward P/E |
|---|---|---|---|---|
| Jan 31, 2026 | $2.69 | $0.03 | 89.7 | 16.5 |
| Feb 1, 2025 | $3.42 | -$0.37 | n/m | — |
| Feb 3, 2024 | $2.48 | -$4.78 | n/m | — |
| Jan 28, 2023 | $11.74 | $0.34 | 34.5 | 16.2 |
| Jan 29, 2022 | $18.30 | $0.62 | 29.5 | 20.1 |
| Jan 30, 2021 | $26.03 | -$0.13 | n/m | — |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Petco Health And Wellness valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| Petco Health And WellnessWOOF | $844M | 26.1 | 9.9 | 0.1 |
| TrupanionTRUP | $1.31B | 56.9 | 7.3 | — |
| ZoetisZTS | $33.4B | 13.0 | 12.6 | 3.5 |
| Idexx LaboratoriesIDXX | $43.5B | 38.7 | 34.9 | 9.6 |
| Peer median | 38.7 | 12.6 | 6.5 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: WOOF financials · WOOF returns
No forecast, no recommendation. This page describes Petco Health And Wellness Company from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.